Although Notch1 plays a vital role in a variety of tumors, most of the clinical trials of Notch1 have showed modest efficacy and only in the initial stage, it is probably due to the complex heterogeneity of glioma and the crosstalk between Notch pathway and other molecules. The gene discussed is NOTCH1; the disease is glioma.